Gilead Sciences
GILD
#98
Rank
S$222.39 B
Marketcap
S$179.17
Share price
2.22%
Change (1 day)
19.83%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): S$8.85

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$8.81. In 2024 the company made an earnings per share (EPS) of S$0.49 a decrease over its 2023 EPS that were of S$5.85.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.851712.07%
2024S$0.49-91.65%
2023S$5.8523.98%
2022S$4.72-25.86%
2021S$6.364850%
2020S$0.13-97.64%
2019S$5.450.9%
2018S$5.4018.71%
2017S$4.55-64.88%
2016S$12.96-18.45%
2015S$15.8955.28%
2014S$10.23296.02%
2013S$2.5817.89%
2012S$2.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.32 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.75-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$3.07-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.60 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.42 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$11.35 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.05-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$19.89 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.40 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA